Berzosertib (VE-822) inhibits gastric cancer cell proliferation via base excision repair system

BACKGROUND: Current investigations suggest that the Base Excision Repair (BER) system may change DNA repair capacity and affect clinical gastric cancer progression such as overall survival. However, the prognostic value of BER system members in gastric cancer remains unclear. METHODS: We explored th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Manag Res
Päätekijät: Ni, Fubiao, Tang, Hengjie, Wang, Cheng, Wang, Zixiang, Yu, Fangyi, Chen, Bicheng, Sun, Linxiao
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove 2019
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6750847/
https://ncbi.nlm.nih.gov/pubmed/31571995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S217375
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia